Table 3 Phase two EBRT component dose constraints
| Structure | Per-Protocol | Minor Variation | Major Variation |
|---|---|---|---|
| PTVebrt D95 | > 46 Gy | 44–46 Gy | < 44 Gy |
| Prostatic Urethra PRV | Dmax < 47 Gy | Dmax: 47–50 Gy | Dmax > 50 Gy |
| Small Bowel | Dmax < 47 Gy | Dmax: 47–50 Gy | Dmax > 50 Gy |
| Neck of Femur | Dmax < 35 Gy | Dmax: 35–45 Gy | Dmax> 45 Gy |
| Rectum V45 | < 25% | 25–35% | > 35% |
| Bladder V45 | < 25% | 25–35% | > 35% |